STOCK TITAN

Axcelis Technologies Inc (ACLS) Financials

ACLS
Trailing 12 months to June 30, 2026
Revenue $866.1M -3.3% YoY
Net Income $92.8M -41.5% YoY
EPS (Diluted) $2.98 -39.1% YoY
Free Cash Flow $65.6M -46.5% YoY
Market Cap $4.2B as of Oct 9, 2026
Price / Sales 4.8x on $866.1M revenue, trailing 12 months to June 30, 2026
Price / Earnings 44.8x on $92.8M net income, trailing 12 months to June 30, 2026
Price / Book 3.9x on $1.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ACLS SEC filings page.

Axcelis Technologies Inc (ACLS) reported $866.1M in revenue over the twelve months to Jun 30, 2026, down 3.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ACLS FY2025

FY2025 shows a profitable but cyclical business: revenue contracted, while gross margin held and operating expenses compressed operating returns.

From FY2023 to FY2025, gross margin edged up to 44.9% even as operating margin fell to 14.2%. With SG&A and R&D reaching $191M in FY2025 while revenue fell to $839M, the gap indicates weaker cost absorption rather than a product-margin problem.

Operating cash flow of $118M nearly matched net income of $120M, showing earnings were broadly cash-backed. Free cash flow was $107M after $11M of capital spending, so reinvestment consumed only a modest portion of internally generated cash.

The balance sheet became more conservative even as operations softened: debt-to-equity fell to 0.3x and current ratio remained 4.8x in FY2025. But inventory rose to $329M while revenue fell to $839M, tying more capital to stock during the downturn.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 67 / 100
Financial Health Score 67/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Axcelis Technologies Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
83

Axcelis Technologies Inc has an operating margin of 14.2%, meaning the company retains $14 of operating profit per $100 of revenue. This strong profitability earns a score of 83/100, reflecting efficient cost management and pricing power. This is down from 20.7% the prior year.

Growth
6

Axcelis Technologies Inc's revenue declined 17.6% year-over-year, from $1.0B to $839.0M. This contraction results in a growth score of 6/100.

Leverage
69

Axcelis Technologies Inc carries a low D/E ratio of 0.32, meaning only $0.32 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 69/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
91

With a current ratio of 4.77, Axcelis Technologies Inc holds $4.77 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 91/100.

Cash Flow
73

Axcelis Technologies Inc converts 12.8% of revenue into free cash flow ($107.0M). This strong cash generation earns a score of 73/100.

Returns
79

Axcelis Technologies Inc earns a strong 11.6% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is down from 19.9% the prior year.

Altman Z-Score Safe
9.72

Axcelis Technologies Inc scores 9.72, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($4.2B) relative to total liabilities ($326.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Axcelis Technologies Inc passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
0.98x

For every $1 of reported earnings, Axcelis Technologies Inc generates $0.98 in operating cash flow ($118.3M OCF vs $120.2M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe
22.24x

Axcelis Technologies Inc earns $22.24 in operating income for every $1 of interest expense ($119.3M vs $5.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$215.2M
YoY+10.6%
QoQ+8.2%
5Y CAGR+7.9%
10Y CAGR+12.8%

Axcelis Technologies Inc generated $215.2M in revenue in Q2 2026. This represents an increase of 10.6% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.

EBITDA
$24.7M
YoY-26.2%
QoQ+99.3%
5Y CAGR-1.6%

Axcelis Technologies Inc's EBITDA was $24.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 26.2% from the same quarter a year earlier. Against the prior quarter it is up 99.3%.

Net Income
$23.3M
YoY-25.8%
QoQ+152.8%
5Y CAGR+4.3%
10Y CAGR+23.0%

Axcelis Technologies Inc reported $23.3M in net income in Q2 2026. This represents a decrease of 25.8% from the same quarter a year earlier. Against the prior quarter it is up 152.8%.

EPS (Diluted)
$0.75
YoY-23.5%
QoQ+150.0%
5Y CAGR+6.4%
10Y CAGR+22.3%

Axcelis Technologies Inc earned $0.75 per diluted share (EPS) in Q2 2026. This represents a decrease of 23.5% from the same quarter a year earlier. Against the prior quarter it is up 150.0%.

Cash & Balance Sheet

Free Cash Flow
$14.8M
YoY-60.7%
QoQ-9.1%
5Y CAGR-13.0%

Axcelis Technologies Inc generated $14.8M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 60.7% from the same quarter a year earlier. Against the prior quarter it is down 9.1%.

Cash & Debt
$155.0M
YoY-10.7%
QoQ+2.8%
5Y CAGR-6.7%
10Y CAGR+9.8%

Axcelis Technologies Inc held $155.0M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
31M
YoY-1.7%
QoQ+0.5%
5Y CAGR-1.7%
10Y CAGR+0.6%

Axcelis Technologies Inc had 31M shares outstanding in Q2 2026. This represents a decrease of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
42.4%
YoY-2.5pp
QoQ+1.9pp
5Y change-1.1pp
10Y change+3.4pp

Axcelis Technologies Inc's gross margin was 42.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.

Operating Margin
9.4%
YoY-5.5pp
QoQ+5.4pp
5Y change-6.9pp

Axcelis Technologies Inc's operating margin was 9.4% in Q2 2026, reflecting core business profitability. This is down 5.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.4 percentage points.

Net Margin
10.8%
YoY-5.3pp
QoQ+6.2pp
5Y change-2.0pp
10Y change+6.3pp

Axcelis Technologies Inc's net profit margin was 10.8% in Q2 2026, showing the share of revenue converted to profit. This is down 5.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.2 percentage points.

Return on Equity
2.2%
YoY-0.9pp
QoQ+1.3pp
5Y change-1.6pp
10Y change+0.7pp

Axcelis Technologies Inc's ROE was 2.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Capital Allocation

R&D Spending
$29.0M
YoY+7.1%
QoQ+1.6%
5Y CAGR+11.8%

Axcelis Technologies Inc invested $29.0M in research and development in Q2 2026. This represents an increase of 7.1% from the same quarter a year earlier. Against the prior quarter it is up 1.6%.

Capital Expenditures
$3.6M
YoY+79.0%
QoQ+93.3%
5Y CAGR+27.7%
10Y CAGR+19.8%

Axcelis Technologies Inc invested $3.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 79.0% from the same quarter a year earlier. Against the prior quarter it is up 93.3%.

Share Buybacks

Not reported for Q2 2026.

ACLS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ACLS quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$215.2M+10.6%$199.0M+3.3%$238.3M-5.6%$213.6M-16.7%$194.5M-24.2%$192.6M-23.7%$252.4M-18.7%$256.6M-12.2%
Cost of Revenue$124.0M+15.7%$118.4M+14.0%$126.4M-7.2%$124.8M-14.9%$107.2M-25.6%$103.8M-23.9%$136.2M-21.0%$146.6M-9.9%
Gross Profit$91.2M+4.4%$80.6M-9.2%$111.9M-3.7%$88.8M-19.2%$87.3M-22.3%$88.8M-23.5%$116.2M-15.7%$110.0M-15.2%
R&D Expenses$29.0M+7.1%$28.5M+5.1%$30.1M+8.9%$24.6M-6.6%$27.1M+5.0%$27.1M+5.7%$27.7M+11.0%$26.4M+9.6%
SG&A Expenses$22.4M+37.2%$26.8M+54.2%$26.2M+50.1%$23.3M+17.4%$16.3M-1.6%$17.4M+5.8%$17.5M+1.2%$19.9M+13.8%
Operating Income$20.3M-30.0%$8.0M-72.7%$36.2M-33.7%$25.0M-46.7%$29.0M-45.2%$29.2M-48.4%$54.5M-31.0%$46.9M-34.6%
EBITDA$24.7M-26.2%$12.4M-63.0%$40.7M-30.8%$29.3M-42.3%$33.5M-41.0%$33.5M-44.5%$58.8M-28.9%$50.8M-32.2%
Interest Expense$1.3M-6.8%$1.3M-5.5%$1.3M-7.4%$1.3M-2.1%$1.4M+1.2%$1.4M+1.6%$1.4M+9.4%$1.3M+0.6%
Income Tax$2.1M-43.2%$1.4M-68.7%$5.7M-34.2%$4.2M-38.7%$3.6M-43.4%$4.5M-39.2%$8.7M-46.9%$6.8M-12.3%
Net Income$23.3M-25.8%$9.2M-67.8%$34.3M-31.3%$26.0M-46.5%$31.4M-38.3%$28.6M-44.6%$50.0M-29.7%$48.6M-26.3%
EPS (Basic)$0.76-23.2%$0.30-66.3%$1.11-27.9%$0.83-44.3%$0.99-36.5%$0.89-43.7%$1.54-29.0%$1.49-25.9%
EPS (Diluted)$0.75-23.5%$0.30-65.9%$1.10-28.6%$0.83-44.3%$0.98-36.8%$0.88-43.9%$1.54-28.4%$1.49-25.1%
Diluted Shares (Avg)31M-2.3%31M-4.2%N/A31M-3.7%32M-2.7%32M-1.8%N/A33M-1.5%

ACLS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ACLS quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$1.4B+4.8%$1.4B+2.5%$1.4B+0.9%$1.4B+1.0%$1.3B+2.7%$1.3B+2.6%$1.3B+5.2%$1.3B+11.4%
Current Assets$979.8M-8.0%$935.7M-16.0%$943.2M-16.1%$984.0M-12.3%$1.1B-1.3%$1.1B+0.8%$1.1B+4.0%$1.1B+10.5%
Cash & Equivalents$155.0M-10.7%$150.8M-18.0%$145.5M+17.8%$187.5M+56.2%$173.6M+19.6%$184.0M+37.3%$123.5M-26.2%$120.1M-15.6%
Short-Term Investments$247.2M-34.3%$215.8M-46.5%$228.8M-48.9%$262.1M-42.9%$376.2M-6.7%$403.1M+1.7%$447.8M+32.2%$459.3M+44.1%
Inventory$338.2M+8.8%$326.1M+10.2%$329.0M+16.6%$324.3M+11.5%$310.8M+9.8%$295.9M-5.2%$282.2M-7.9%$291.0M-6.8%
Accounts Receivable$154.1M+11.0%$161.8M-1.9%$168.5M-17.1%$147.6M-19.6%$138.8M-26.2%$164.9M-20.9%$203.1M-6.8%$183.5M-4.6%
Long-Term Investments$174.8M+461.9%$203.3M$182.4M$143.2M$31.1M$0$0$0
Total Liabilities$321.0M+6.6%$329.9M+5.3%$326.7M-2.8%$331.8M-8.5%$301.1M-14.8%$313.4M-22.6%$336.0M-19.4%$362.5M-9.5%
Current Liabilities$200.1M+13.0%$203.9M+1.8%$197.7M-4.8%$199.0M-21.1%$177.1M-27.5%$200.4M-27.6%$207.5M-27.2%$252.3M-3.4%
Non-Current Liabilities$120.9M-2.5%$126.0M+11.5%$129.0M+0.4%$132.8M+20.4%$124.0M+13.5%$113.0M-11.9%$128.5M-2.6%$110.3M-21.0%
Total Equity$1.1B+4.2%$1.0B+1.7%$1.0B+2.2%$1.0B+4.6%$1.0B+9.4%$1.0B+13.9%$1.0B+17.1%$975.6M+21.8%
Retained Earnings$536.0M+10.0%$512.8M+5.6%$503.5M+7.1%$488.8M+13.0%$487.2M+22.8%$485.7M+35.5%$470.3M+47.2%$432.4M+65.4%

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

ACLS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ACLS quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$18.4M-53.8%$18.1M-54.4%-$6.6M-151.4%$45.4M-0.9%$39.7M-0.8%$39.8M-5.8%$12.8M-80.5%$45.7M+90.5%
Depreciation & Amortization$4.4M-2.2%$4.4M+2.9%$4.5M+4.5%$4.3M+10.3%$4.5M+15.4%$4.3M+14.1%$4.3M+19.2%$3.9M+20.7%
Stock-Based Compensation$6.4M+18.5%$4.9M-0.1%N/A$5.3M-1.9%$5.4M-1.8%$4.9M+4.5%N/A$5.4M+5.9%
Capital Expenditures$3.6M+79.0%$1.8M-62.9%$2.3M-49.9%$2.0M-48.3%$2.0M-0.9%$5.0M+206.2%$4.7M-54.1%$3.9M-26.4%
Free Cash Flow$14.8M-60.7%$16.3M-53.2%-$8.9M-209.6%$43.3M+3.6%$37.7M-0.8%$34.8M-14.2%$8.1M-85.3%$41.8M+123.6%
Investing Cash Flow-$6.1M-32.2%-$10.6M-126.3%-$7.3M-180.1%$1.4M+102.4%-$4.6M+17.7%$40.5M+172.7%$9.1M+134.2%-$56.6M-5909.9%
Financing Cash Flow-$7.9M+83.3%-$1.4M+93.1%-$24.6M-69.3%-$32.8M-104.9%-$47.0M-107.9%-$20.1M-11.4%-$14.5M+3.2%-$16.0M-21.5%
Share BuybacksN/AN/A$25.2M+66.8%$32.3M+110.5%$45.3M+202.3%$18.2M+21.2%$15.1M+0.9%$15.4M+22.9%

Not reported in any period shown, so not listed: Dividends Paid.

ACLS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ACLS quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin42.4%-2.5pp40.5%-5.6pp47.0%+0.9pp41.6%-1.3pp44.9%+1.1pp46.1%+0.1pp46.0%+1.6pp42.9%-1.5pp
Operating Margin9.4%-5.5pp4.0%-11.1pp15.2%-6.4pp11.7%-6.6pp14.9%-5.7pp15.1%-7.3pp21.6%-3.9pp18.3%-6.2pp
Net Margin10.8%-5.3pp4.6%-10.2pp14.4%-5.4pp12.2%-6.8pp16.1%-3.7pp14.8%-5.6pp19.8%-3.1pp18.9%-3.6pp
Return on Equity2.2%-0.9pp0.9%-1.9pp3.3%-1.6pp2.5%-2.4pp3.1%-2.4pp2.8%-2.9pp4.9%-3.3pp5.0%-3.3pp
Return on Assets1.7%-0.7pp0.7%-1.5pp2.5%-1.2pp1.9%-1.7pp2.4%-1.6pp2.1%-1.8pp3.7%-1.8pp3.6%-1.9pp
Current Ratio4.90-1.1x4.59-1.0x4.77-0.6x4.95+0.5x6.01+1.6x5.56+1.6x5.41+1.6x4.45+0.6x
Debt-to-Equity0.300.0x0.320.0x0.320.0x0.330.0x0.29-0.1x0.31-0.1x0.33-0.2x0.37-0.1x
Asset Turnover0.160.0x0.140.0x0.180.0x0.160.0x0.15-0.1x0.140.0x0.19-0.1x0.19-0.1x
FCF Margin6.9%-12.5pp8.2%-9.9pp-3.7%-7.0pp20.3%+4.0pp19.4%+4.6pp18.1%+2.0pp3.2%-14.6pp16.3%+9.9pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Axcelis Technologies Inc ACLS FY2025 $839.0M $120.2M 14.3% $4.2B 67/100
FormFactor Inc. FORM FY2025 $785.0M $54.4M 6.9% $10.7B 67/100
IPG Photonics Corporation IPGP FY2025 $1.0B $31.1M 3.1% $3.3B 51/100
Camtek Ltd CAMT FY2025 $496.1M $50.7M 10.2% $7.0B 82/100
Kulicke & Soffa Industries Inc KLIC FY2025 $654.1M $213K 0.0% $4.8B 48/100
Ambarella, Inc. AMBA FY2026 $390.7M -$75.9M -19.4% $2.8B 61/100

Frequently Asked Questions

What is Axcelis Technologies Inc's annual revenue?

Axcelis Technologies Inc (ACLS) reported $839.0M in total revenue for fiscal year 2025. This represents a -17.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Axcelis Technologies Inc's revenue growing?

Axcelis Technologies Inc (ACLS) revenue declined by 17.6% year-over-year, from $1.0B to $839.0M in fiscal year 2025.

Is Axcelis Technologies Inc profitable?

Yes, Axcelis Technologies Inc (ACLS) reported a net income of $120.2M in fiscal year 2025, with a net profit margin of 14.3%.

Axcelis Technologies Inc (ACLS) reported diluted earnings per share of $3.80 for fiscal year 2025. This represents a -38.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Axcelis Technologies Inc (ACLS) had EBITDA of $136.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Axcelis Technologies Inc (ACLS) had a gross margin of 44.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Axcelis Technologies Inc (ACLS) had an operating margin of 14.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Axcelis Technologies Inc (ACLS) had a net profit margin of 14.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Axcelis Technologies Inc (ACLS) has a return on equity of 11.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Axcelis Technologies Inc (ACLS) generated $107.0M in free cash flow during fiscal year 2025. This represents a -16.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Axcelis Technologies Inc (ACLS) generated $118.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Axcelis Technologies Inc (ACLS) had $1.4B in total assets as of fiscal year 2025, including both current and long-term assets.

Axcelis Technologies Inc (ACLS) invested $11.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Axcelis Technologies Inc (ACLS) invested $109.0M in research and development during fiscal year 2025.

Yes, Axcelis Technologies Inc (ACLS) spent $121.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Axcelis Technologies Inc (ACLS) had 31M shares outstanding as of fiscal year 2025.

Axcelis Technologies Inc (ACLS) had a current ratio of 4.77 as of fiscal year 2025, which is generally considered healthy.

Axcelis Technologies Inc (ACLS) had a debt-to-equity ratio of 0.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Axcelis Technologies Inc (ACLS) had a return on assets of 8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Axcelis Technologies Inc (ACLS) trades at 44.8x earnings, its market capitalization divided by net income of $92.8M net income, trailing 12 months to June 30, 2026. The market capitalization is $4.2B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Axcelis Technologies Inc (ACLS) trades at 4.8x sales, its market capitalization divided by revenue of $866.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.2B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Axcelis Technologies Inc (ACLS) has an Altman Z-Score of 9.72, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Axcelis Technologies Inc (ACLS) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Axcelis Technologies Inc (ACLS) has an earnings quality ratio of 0.98x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Axcelis Technologies Inc (ACLS) has an interest coverage ratio of 22.24x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Axcelis Technologies Inc (ACLS) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top